Literature DB >> 5831217

Poisoning with organophosphorus insecticides.

W J Taylor, W Kalow, E A Sellers.   

Abstract

Because of an increasing incidence of poisoning with the newer organophosphorus anticholinesterase insecticides, these compounds have been reviewed in terms of their history and pharmacology, relationship with other drugs, factors affecting toxicity, mechanism of action, toxic signs and treatment. The modern organophosphorus pesticide requires metabolic conversion before toxicity develops. Insects have a greater propensity for this conversion than humans. Nevertheless, this conversion does occur in humans and can be potentiated by other drugs. Toxicity also varies with age, sex, route and frequency of administration, and previous exposure. The mechanism of toxicity is inhibition of acetylcholinesterase, causing an intoxicating build-up of acetylcholine. Signs and symptoms consist of the clinical manifestations of unopposed parasympathetic and central activity. Treatment must be initiated early. Respiration must be maintained and the effects of acetylcholine must be counteracted by massive doses of atropine. Metaraminol enhances the antagonistic action of atropine against acetylcholine and may also be given. Once acetylcholinesterase is inactivated, restoration is slow. Recovery can be accelerated by enzyme reactivators like the oxime compounds. Pyridine aldoxime (Pralidoxime, Protopam, P(2)S and 2-PAM) can be given in combination with atropine and metaraminol (AMP therapy) and may be the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5831217      PMCID: PMC1928990     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  23 in total

1.  PUBLIC HEALTH AND PESTICIDES.

Authors:  R TAYLOR
Journal:  Appl Ther       Date:  1963-11

2.  Parathion poisoning successfully treated with 2-PAM (pralidoxime chloride).

Authors:  H JACOBZINER; H W RAYBIN
Journal:  N Engl J Med       Date:  1961-08-31       Impact factor: 91.245

3.  Occupational disease in California attributed to pesticides and agricultural chemicals.

Authors:  G D KLEINMAN; I WEST; M S AUGUSTINE
Journal:  Arch Environ Health       Date:  1960-08

4.  ACCIDENTAL PARATHION POISONING.

Authors:  A B MACMILLAN
Journal:  Appl Ther       Date:  1964-02

5.  [Action of chlorpromazine on phosphatase and cholinesterase activity of blood].

Authors: 
Journal:  C R Seances Soc Biol Fil       Date:  1955-10

6.  [Effect of synthetic hibernation-inducing drugs on serum and erythrocyte cholinesterase, with consideration of simultaneous circulation analyses].

Authors:  W BENSTZ
Journal:  Klin Wochenschr       Date:  1956-08-01

7.  Parathion poisoning. A nearfatal pediatric case treated with 2-pyridine aldoxime methiodide (2-PAM).

Authors:  G E QUINBY; G B CLAPPISON
Journal:  Arch Environ Health       Date:  1961-11

8.  The effects of DFP on the convulsant dose of theophylline, theophylline-ethylenediamine and 8-chlorotheophylline.

Authors:  R J JOHNS; P D BALES; H E HIMWICH
Journal:  J Pharmacol Exp Ther       Date:  1951-02       Impact factor: 4.030

9.  Protective effect of phenothiazine derivatives against poisoning by the irreversible cholinesterase inhibitor dimethylamidoethoxyphosphoryl cyanide (tabun).

Authors:  R DAHLBOM; H DIAMANT; T EDLUND; T EKSTRAND; B HOLMSTEDT
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1953

10.  ESTERASE INHIBITORS AS PESTICIDES.

Authors:  J E CASIDA
Journal:  Science       Date:  1964-11-20       Impact factor: 47.728

View more
  3 in total

1.  Ecogenetic studies in Atacameño Indians.

Authors:  H W Goedde; F Rothhammer; H G Benkmann; P Bogdanski
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.

Authors:  R F Mueller; S Hornung; C E Furlong; J Anderson; E R Giblett; A G Motulsky
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

3.  Effects of a combination of atropine, metaraminol and pyridine aldoxime methanesulfonate (AMP therapy) on normal human subjects.

Authors:  W J Taylor; E Llewellyn-Thomas; E A Sellers; G C Walker
Journal:  Can Med Assoc J       Date:  1965-10-30       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.